Early Colorectal Cancer Screening: Who’s At Risk?
- Colorectal cancer, once largely considered a disease of older adults, is increasingly diagnosed in younger people.
- Preventive Services Task Force (USPSTF) both recommend beginning regular colorectal cancer screening at age 45 for people at average risk.
- For those aged 45 to 75, screening options fall into two main categories: stool-based tests and visual exams.
Colorectal cancer, once largely considered a disease of older adults, is increasingly diagnosed in younger people. While the reasons for this shift are still being investigated, experts emphasize the importance of understanding screening guidelines and recognizing potential risk factors. Current recommendations focus on initiating regular screening at age 45 for individuals at average risk, but certain conditions may warrant earlier or more frequent testing.
Understanding Screening Recommendations
The American Cancer Society and the U.S. Preventive Services Task Force (USPSTF) both recommend beginning regular colorectal cancer screening at age 45 for people at average risk. , the CDC highlights that most individuals should begin screening soon after turning 45 and continue at regular intervals.
For those aged 45 to 75, screening options fall into two main categories: stool-based tests and visual exams. Stool-based tests, such as the highly sensitive fecal immunochemical test (FIT) or the guaiac-based fecal occult blood test (gFOBT), can be administered annually. A multi-targeted stool DNA test, combining fecal immunochemical testing with a DNA analysis, is another option, performed every three years. Visual exams, which directly examine the colon and rectum, include colonoscopy and sigmoidoscopy.
The decision to continue screening between ages 76 and 85 should be individualized, taking into account a person’s overall health, life expectancy, and prior screening history. Individuals over the age of 85 are generally no longer recommended to undergo colorectal cancer screening.
Who is Considered at Average Risk?
Being considered at “average risk” means an individual does not have a personal history of colorectal cancer or certain types of polyps, a family history of the disease, a personal history of inflammatory bowel disease (such as Crohn’s disease or ulcerative colitis), a confirmed or suspected hereditary colorectal cancer syndrome (like familial adenomatous polyposis or Lynch syndrome), or a history of radiation to the abdomen or pelvic area for prior cancer treatment.
Increased Risk and Earlier Screening
Individuals falling outside the “average risk” category should discuss screening options with their doctor. People with Crohn’s disease or ulcerative colitis, a family history of colorectal cancer or polyps, or certain genetic conditions may need to begin screening earlier than age 45 and/or undergo more frequent testing.
Specifically, those with inflammatory bowel disease, a personal or family history of colorectal cancer or polyps, or a genetic syndrome such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colorectal cancer (Lynch syndrome) should have a personalized screening plan developed with their healthcare provider.
Understanding the Screening Tests
Several tests are available for colorectal cancer screening, each with its own advantages and disadvantages. Stool-based tests are non-invasive and can be performed at home, but they may not detect all cancers. Visual exams are more invasive but allow for direct visualization of the colon and rectum, and the removal of precancerous polyps during the procedure.
The USPSTF recommends screening with one of several methods, noting that the net benefit of screening all persons aged 76 to 85 is small, and decisions should be made on an individual basis. The choice of test should be made in consultation with a healthcare provider, considering individual risk factors, preferences, and the availability of resources.
The Rising Incidence in Younger Adults
Recent reports indicate a concerning trend: an increase in colorectal cancer diagnoses among younger adults, including Millennials and Generation Z. While the exact causes are still under investigation, factors such as changes in diet, lifestyle, and the gut microbiome are being explored. This trend underscores the importance of awareness and adherence to screening guidelines, even for those under the traditionally recommended age of 50.
Early detection remains the most effective strategy for improving outcomes in colorectal cancer. By understanding the risk factors, screening options, and current recommendations, individuals can take proactive steps to protect their health.
It is crucial to remember that this information is for general knowledge and informational purposes only, and does not constitute medical advice. Individuals should always consult with a qualified healthcare professional for any health concerns or before making any decisions related to their health or treatment.